Product Introduction

Zoryl M2 Tablet is a combination medicine used to treat type 2 diabetes mellitus in adults. It helps in controlling blood sugar levels, preventing complications like kidney damage, blindness, nerve problems, and loss of limbs. This tablet contains two antidiabetic agents: Glimepiride and Metformin, which work together to regulate blood glucose levels effectively.

Zoryl M2 should be taken with meals to minimize the chances of gastrointestinal discomfort. Taking it regularly at the same time each day improves blood sugar control and enhances its effectiveness. It is important to maintain a balanced diet and active lifestyle while using this medicine.

Uses of Zoryl M2 Tablet

• Type 2 Diabetes Mellitus

Benefits of This Medicine

Zoryl M2 Tablet helps improve blood sugar control in adults with type 2 diabetes. It reduces the risk of serious complications such as heart disease, nerve damage, eye problems, and kidney failure. In combination with diet and exercise, this medicine helps you lead a healthier and more active life.

Possible Side Effects

This medicine may cause some side effects initially, but they typically subside as your body adjusts to the treatment. Contact your doctor if any side effect persists or worsens.

• Nausea
• Vomiting
• Diarrhea
• Stomach pain
• Loss of appetite
• Hypoglycemia (low blood sugar) — more likely if meals are skipped

How to Use

Take Zoryl M2 Tablet exactly as prescribed by your doctor. Swallow the tablet whole with water. Do not chew or crush it. It is best taken with meals to reduce the risk of stomach upset and to enhance effectiveness.

How It Works

Zoryl M2 contains:

• Glimepiride: A sulfonylurea that stimulates the pancreas to release insulin.
• Metformin: A biguanide that decreases glucose production in the liver and improves insulin sensitivity.

The combination improves overall glycemic control by targeting insulin resistance and enhancing insulin secretion.

Frequently Asked Questions (FAQs)

References:
NCBI – Glimepiride Profile
NCBI – Metformin Profile
WHO – Diabetes Treatment Guidelines